A New Era in Managing Cancer-Associated Thrombosis

Speciality: Oncology

Description:

In this highly informative and engaging webinar, Dr. Abhay Bhave, a renowned hematologist, sheds light on the growing clinical challenge of Cancer-Associated Thrombosis (CAT) and its significant impact on cancer care. CAT, primarily presenting as Venous Thromboembolism (VTE), is one of the leading causes of death in cancer patients and is known to be three times more prevalent in cancer patients compared to the general population. Dr. Bhave explains the underlying mechanisms, such as tumor-induced vein compression and venous stasis, which significantly contribute to the development of thrombosis in cancer patients.

He discusses initial and widely accepted treatment options including Low Molecular Weight Heparin (LMWH), unfractionated heparin (UFH), and fondaparinux, while also exploring newer therapeutic approaches and the direction of current research in the field. This session is designed to break the clinical inertia often observed in the proactive management of VTE in oncology settings.

Whether you're a clinician, oncologist, or healthcare professional, this session offers valuable insights and practical guidance to improve patient care and outcomes.

Don’t miss this opportunity to upgrade your knowledge. Watch the full session and follow HiDoc for more expert-led medical webinars.

See More Webinars @ Hidoc Webinars

See More Webinars @ Hidoc Webinars